2021
DOI: 10.1002/ajh.26344
|View full text |Cite
|
Sign up to set email alerts
|

Red blood cell lifespan is reduced in severe aplastic anemia and improves with response to immunosuppressive treatment

Help me understand this report

Search citation statements

Order By: Relevance

Paper Sections

Select...
1

Citation Types

0
1
0

Year Published

2023
2023
2024
2024

Publication Types

Select...
2

Relationship

0
2

Authors

Journals

citations
Cited by 2 publications
(1 citation statement)
references
References 3 publications
0
1
0
Order By: Relevance
“…In healthy individuals, erythrocytes usually survive for an average of 120 days [1]. However, previous research has demonstrated that several conditions, including hereditary xerocytosis (HX), severe aplastic anemia (SAA), and sickle cell anemia (SCA), may result in a shortened lifespan of erythrocytes, leading to anemia [2][3][4][5][6][7]. Patients with renal insufficiency may experience varying degrees of anemia [8,9] that could be linked to reduced production of endogenous erythropoietin (EPO) and iron deficiency [10,11].…”
Section: Introductionmentioning
confidence: 99%
“…In healthy individuals, erythrocytes usually survive for an average of 120 days [1]. However, previous research has demonstrated that several conditions, including hereditary xerocytosis (HX), severe aplastic anemia (SAA), and sickle cell anemia (SCA), may result in a shortened lifespan of erythrocytes, leading to anemia [2][3][4][5][6][7]. Patients with renal insufficiency may experience varying degrees of anemia [8,9] that could be linked to reduced production of endogenous erythropoietin (EPO) and iron deficiency [10,11].…”
Section: Introductionmentioning
confidence: 99%